CAPR News

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Rosen Law Firm Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR

Capricor Therapeutics Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact The Firm to Possibly Recover Losses

CAPR Investor Alert: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. (CAPR) for Potential Securities Fraud

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Investigation Opened Following Massive Stock Crash

CAPR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. For Possible Securities Law Violations

Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Announced Concerning FDA Review And Advisory Committee Meeting - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Levi & Korsinsky Announces Investigation of Securities Claims Against Capricor Therapeutics, Inc. (CAPR)

Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Capricor Stockholders and Encourages Investors to Contact the Firm